Itay & Beyond

Pioneering biotech startup revolutionizing neuropsychiatric drug discovery through its groundbreaking platform.

Health Tech & Life Sciences
Active
Pre-Funding Jerusalem, Israel Founded 2021
Last updated 2026-07-20
Total raised
Stage
Pre-Funding
Founded
2021
Headcount
15
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Itay & Beyond is an Israeli biotech startup that integrates patient-derived brain organoids with advanced AI analysis to predict drug efficacy for neurological and psychiatric disorders. The company's platform aims to improve drug development by providing accurate human-based models, reducing reliance on animal testing, and enhancing patient outcomes. The company was founded in 2021, inspired by co-founder Shmulik Bezalel's son, Itay, who has Autism Spectrum Disorder (ASD), and the urgent need for more effective treatments for neuropsychiatric disorders. Their technology, validated in a 200-patient study at Hadassah Medical Center, combines patient-derived brain organoids, a bio-dynamic processing unit, and advanced AI analysis to dramatically improve drug efficacy predictions. Itay & Beyond is a neurotech CNS company pioneering patient-derived brain organoid technologies enabling functional brain-on-a-chip readouts and AI-driven analytics for neuropsychiatric and neurological diseases. The company is building a scalable CNS discovery and development platform designed to improve translational predictivity, support disease subpopulation stratification, and accelerate the identification and development of more relevant therapeutic candidates.

Headcount over time

From 9 (2025-03) to 15 (2026-03) · +6 (+67%) · 5 points · source: Finder history + radar grounding
170 2025-03 2026-03

Q&A

What is Itay & Beyond's primary focus?
Itay & Beyond is a biotech startup focused on revolutionizing neuropsychiatric drug discovery using patient-derived lab-grown brain tissue on a chip to develop novel treatments for neurology and psychiatry.
When was Itay & Beyond founded?
Itay & Beyond was founded in January 2021.
How many employees does Itay & Beyond currently have?
Itay & Beyond has 11-50 employees.
What is Itay & Beyond's current funding stage?
Itay & Beyond is currently in the Pre-Funding stage.
Who is the Co-founder and CEO of Itay & Beyond?
Nissim Perets is the Co-founder and CEO of Itay & Beyond.
What is the product stage of Itay & Beyond?
The product stage of Itay & Beyond is R&D.
Where is Itay & Beyond headquartered?
Itay & Beyond is headquartered in Jerusalem, Israel.
What sectors does Itay & Beyond operate in?
Itay & Beyond operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, and Digital Healthcare.

Team · 3

Dr. Nisim Perets
Founder · Co-Founder and CEO
Shmulik Bezalel
Founder · Co-Founder and Investor
Boaz Goldman
Founder · Co-Founder and Investor

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDigital Healthcare
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnologyHealthcarePatients

Tags

drug-discoveryneuroscience
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)